PhoenixBio develops and provides PXB-mice (human hepatocyte chimeric mice), in which over 70% of the mouse liver is replaced with human hepatocytes, along with contract testing services for pharmaceutical R&D. The company's core offerings include DMPK/toxicology studies, hepatitis efficacy evaluations, and sales of freshly isolated human hepatocytes (PXB-cells) to support preclinical drug development. PXB-mouse is the most widely used human hepatocyte chimeric mouse globally, with the company producing over 4,000 animals annually and supporting clients across major pharmaceutical markets including Japan, the US, and Europe.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →PhoenixBio develops and provides PXB-mice (human hepatocyte chimeric mice), in which over 70% of the mouse liver is replaced with human hepatocytes, along with contract testing services for pharmaceutical R&D. The company's core offerings include DMPK/toxicology studies, hepatitis efficacy evaluations, and sales of freshly isolated human hepatocytes (PXB-cells) to support preclinical drug development. PXB-mouse is the most widely used human hepatocyte chimeric mouse globally, with the company producing over 4,000 animals annually and supporting clients across major pharmaceutical markets including Japan, the US, and Europe.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →